Arcturus Therapeutics Holdings (ARCT) Invested Capital (2018 - 2025)

Arcturus Therapeutics Holdings (ARCT) has 4 years of Invested Capital data on file, last reported at $3.5 million in Q3 2023.

• Quarterly Invested Capital fell 87.39% year-over-year to $3.5 million in Q3 2023, while the trailing twelve-month figure through Jun 2024 was $3.5 million (down 90.07% YoY) and the FY2022 annual result came in at $7.5 million, down 66.77% from the prior year.
• Invested Capital declined to $3.5 million in Q3 2023, from $7.5 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $27.7 million in Q3 2022 to a low of $1.2 million in Q4 2020.
• A 4-year average of $14.0 million and a median of $13.0 million in 2021 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2021 — Invested Capital jumped 1697.92% — and 2023, when it sank 87.39%.
• Tracing ARCT's Invested Capital over 4 years: stood at $1.2 million in 2020, then jumped by 1697.92% to $22.5 million in 2021, then tumbled by 66.77% to $7.5 million in 2022, then slumped by 53.24% to $3.5 million in 2023.
• The last three Invested Capital figures came in at $3.5 million (Q3 2023), $7.5 million (Q4 2022), and $27.7 million (Q3 2022), per Business Quant data.